Companies · Healthtech

G Medical Innovations Holdings Ltd.

REHOVOT · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on G Medical Innovations Holdings Ltd. — recommendation, valuation, rhythm, risks.
$20.6M
Total raised · real
3
Rounds
0.1×
Latest step-up
Top 21%
Sector rank · raised
Series A
Latest stage · inferred · Fri Sep 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

G Medical Innovations Holdings Ltd. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.08× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.
At-risk
  • Last raise 2.8 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

G Medical Innovations Holdings Ltd. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.4 yr record
Peak capital year was 2022 with $20.1M across 2 filings.
Market position
ahead of 80% of Healthtech peers
Capital scale is ahead of 80% of Healthtech peers; modeled value is above 18% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $20.1M across 2 filings.
  • Largest single filing was $12.1M on 2022-02-02.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

G Medical Innovations Holdings Ltd. is one of 2138 Healthtech companies tracked from REHOVOT. By capital raised it ranks in the upper tier (ahead of 80% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2023-09-29
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2022-02-02 Raised $12M (real) Modeled valuation $150M (est)$12M$150MSeries A2022Series A · 2022-04-18 Raised $8.0M (real) Modeled valuation $92M (est)$8.0M$92MSeries A2022Series A · 2023-09-29 Raised $500K (real) Modeled valuation $3.3M (est)$500K$3.3MSeries A2023+$8.0M+$500KCumulative $21M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$12.1M · 2022
Series A extension$8.0M · 2022
Series A extension$500K · 2023

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$3.3M
Base estimate est.
$641K
Conservative case
$8.6M
Upside case
$2.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $150.0M · 2022-02-022022Series A · modeled $91.8M · 2022-04-18Series A · modeled $3.3M · 2023-09-292023
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.46×/yr
Annual markup
1.84×/yr upside case
2.8 yr
Elapsed time used
2.8 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$12.5M/yr
Capital velocity
4.4 yr
On record since
2022
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.6× above median
This company$20.6M
Sector median$4.5M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.1× of median
This company$500K
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$3.3M
Sector median$33.8M

Raised more than 80% of sector peers (real $). Modeled value above 18% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #183 of 190.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Nayya Health, Inc. · Series A Raised $15.0M · modeled $183.1M (est)Nue Life Health Inc. · Series A Raised $18.6M · modeled $182.9M (est)W Health Studio, Inc. · Series A Raised $13.0M · modeled $157.6M (est)Avant-garde Health, Inc. · Series A Raised $16.5M · modeled $155.7M (est)Kinetik Healthcare Solutions, Inc · Series A Raised $19.5M · modeled $138.0M (est)Acclivity Health Solutions, Inc. · Series A Raised $21.4M · modeled $135.1M (est)Midi Health, Inc. · Series A Raised $13.9M · modeled $133.3M (est)Orbi Health, Inc. · Series A Raised $10.7M · modeled $120.0M (est)Levels Health Inc. · Series A Raised $34.0M · modeled $119.5M (est)Phoenix Animal Wellness, Inc. · Series A Raised $15.0M · modeled $115.5M (est)Leda Health Corp · Series A Raised $9.4M · modeled $112.1M (est)Juno Care Systems, Inc. · Series A Raised $10.7M · modeled $111.7M (est)G Medical Innovations Holdings Ltd. (this company) Raised $20.6M · modeled $3.3M (est)G Medical Innovations Holdings Ltd.
CompanyStageRaised · realValue · estvs peer med.
Nayya Health, Inc.Series A$15.0M$183.1M4.39×
Nue Life Health Inc.Series A$18.6M$182.9M4.38×
W Health Studio, Inc.Series A$13.0M$157.6M3.77×
Avant-garde Health, Inc.Series A$16.5M$155.7M3.73×
Kinetik Healthcare Solutions, IncSeries A$19.5M$138.0M3.31×
Acclivity Health Solutions, Inc.Series A$21.4M$135.1M3.24×
Midi Health, Inc.Series A$13.9M$133.3M3.19×
Orbi Health, Inc.Series A$10.7M$120.0M2.87×
Levels Health Inc.Series A$34.0M$119.5M2.86×
Phoenix Animal Wellness, Inc.Series A$15.0M$115.5M2.77×
Leda Health CorpSeries A$9.4M$112.1M2.68×
Juno Care Systems, Inc.Series A$10.7M$111.7M2.68×
G Medical Innovations Holdings Ltd. this companySeries A$20.6M$3.3M0.08×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$12.1M2022-02-02$55.0M$150.0M90%
Series A$8.0M2022-04-18$36.4M$91.8M90%
Series A$500K2023-09-29$2.3M$3.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$12.1M2022-02-02
    • First recorded raise — entered as Series A.
    • 2 investors on this round.
  2. Series A$8.0M2022-04-18
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  3. Series A$500K2023-09-29
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 16.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2024 ~Q3
Modeled next raise · ~10mo cadence
$500K
Modeled next size est.range $500K$800K
0.1×
Last step-up
$12.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Chanan Epstein1 other2022-02
David Seligman1 other2023-09
Kenneth Melani1 other2022-02
Benny Tal2022-02
Brendan De Kauwe2022-02
Dror Nuriel-Roth2022-02
Kobi Ben-Efraim2022-02
Oded Shahar2022-02
Urs Wettstein2022-02
Yacov Geva2022-02
Yehoshua Gleitman2022-02
Yeshoshua Jacob Gleitman2023-09
Zeev Rotstein2022-02
Registry & provenance

G Medical Innovations Holdings Ltd. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1760764
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
KitoTech Medical, Inc.HealthtechSeries A$20.5M$1.0Msame sector · same stage
OpenLoop Health, Inc.HealthtechSeries A$21.3M$2.3Msame sector · same stage
Vsee Health, Inc.HealthtechSeries A$23.6M$2.7Msame sector · same stage
Intus Care Inc.HealthtechSeries A$25.2M$1.4Msame sector · same stage
Nudj Health, Inc.HealthtechSeries A$16.4M$1.5Msame sector · same stage
WEconnect Health Management SPCHealthtechSeries A$15.9M$1.1Msame sector · same stage
RF Code, Inc.Other TechnologySeries A$19.6M$183.8Mnetwork1 shared operator · same stage
Prosperity Health Partners LLCHealthtechSeries A$15.6M$3.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Medical Innovation Holdings, Inc.HealthtechPre-Seed$10.1M90%
G-Tech Medical, Inc.HealthtechSeries A$150.7M88%
GVC Health Technology Holdings Inc.HealthtechPre-Seed$10.9M88%
Gt Medical Technologies, Inc.HealthtechSeries C$396.5M86%
Medical Engineering Innovations, Inc.HealthtechSeed$44.5M85%
Gatc Db Care CorpHealthtechSeed$28.8M85%
Gatc Health CorpHealthtechSeries B$5.6M85%
GIE Medical, Inc.HealthtechSeries A$34.0M85%
Frequently asked
How much funding has G Medical Innovations Holdings Ltd. raised?
G Medical Innovations Holdings Ltd. has raised approximately $20.6M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is G Medical Innovations Holdings Ltd.'s estimated valuation?
Provath's modeled valuation for G Medical Innovations Holdings Ltd. is approximately $3.3M (modeled range $641K–$8.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is G Medical Innovations Holdings Ltd. at?
G Medical Innovations Holdings Ltd.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Sep 29.
What does G Medical Innovations Holdings Ltd. do and where is it based?
G Medical Innovations Holdings Ltd. operates in the Healthtech sector, based in REHOVOT.
Explore related

See where G Medical Innovations Holdings Ltd. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at G Medical Innovations Holdings Ltd., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.